Chronic myeloid leukemia (CML) is a hematopoietic malignancy that results from the t(9;22)(q34;q11) Philadelphia (Ph) chromosome translocation, which produces the BCR/ABL fusion oncogene [1-3]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.